Abstract
SUMMARYSome of the important developments in breast cancer treatment and biology are highlighted from presentations made at the 25th San Antonio Breast Cancer Symposium 2002 (San Antonio, Texas, 11-14 December 2002). These include an updated analysis of the ATAC trial, new data demonstrating the superiority of dose-dense adjuvant chemotherapy over conventional scheduling, and recent developments in the field of proteomics.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call